TRUIST FINANCIAL CORP - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
TRUIST FINANCIAL CORP ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$658,117
-33.7%
14,310
-17.1%
0.00%
-50.0%
Q2 2023$992,277
-20.8%
17,266
-48.3%
0.00%0.0%
Q1 2023$1,252,650
+56.5%
33,404
+16.9%
0.00%
+100.0%
Q4 2022$800,475
+259.0%
28,568
+260.3%
0.00%
Q3 2022$223,000
-66.9%
7,928
-59.1%
0.00%
-100.0%
Q2 2022$674,000
-3.2%
19,3760.0%0.00%0.0%
Q1 2022$696,000
+54.3%
19,3760.0%0.00%0.0%
Q4 2021$451,000
+22.6%
19,3760.0%0.00%0.0%
Q3 2021$368,000
-21.0%
19,376
-16.1%
0.00%0.0%
Q2 2021$466,00023,0980.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders